Velcade and Sorafenib in Unresected or Metastatic Renal Cell Carcinoma

NCT01100242 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

17

Enrollment

OTHER

Sponsor class

Stopped Low accrual

Conditions

Metastatic Renal Cell Carcinoma

Interventions

DRUG: Velcade and Sorafenib

Sponsor

New Mexico Cancer Research Alliance